Meeder Asset Management Inc Nektar Therapeutics Transaction History

Meeder Asset Management Inc

$1.58 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $24 - $41	-8 Reduced 6.02%	125 $0
Q2 2022 Aug 08, 2022	SELL	$3.17 - $6.17 $938 - $1,826	-296 Reduced 69.0%	133 $1,000
Q1 2022 May 10, 2022	BUY	$4.16 - $13.72 $1,784 - $5,885	429 New	429 $2,000
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $519 - $883	-48 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$13.07 - $18.84 $4,574 - $6,594	-350 Reduced 87.94%	48 $1,000

Q2 2021 Aug 09, 2021	BUY	$16.52 - $20.4 $5,567 - $6,874	337 Added 552.46%	398 $7,000
Q4 2020 Feb 09, 2021	SELL	$15.77 - $19.03 $126 - $152	-8 Reduced 11.59%	61 $1,000
Q3 2020 Nov 02, 2020	SELL	$16.59 - $24.79 $2,123 - $3,173	-128 Reduced 64.97%	69 $1,000
Q2 2020 Aug 11, 2020	SELL	$16.86 - $23.44 $7,823 - $10,876	-464 Reduced 70.2%	197 $5,000
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $5,165 - $9,981	357 Added 117.43%	661 $12,000
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $809 - $1,179	51 Added 20.16%	304 $7,000
Q3 2019 Oct 17, 2019	SELL	$16.91 - $36.27 $369,162 - $791,810	-21,831 Reduced 98.85%	253 $5,000
Q2 2019 Aug 05, 2019	BUY	$31.0 - $36.3 $659,866 - $772,681	21,286 Added 2667.42%	22,084 $786,000
Q1 2019 Apr 16, 2019	BUY	$31.58 - $46.35 $15,126 - $22,201	479 Added 150.16%	798 $27,000
Q4 2018 Jan 17, 2019	SELL	$30.43 - $56.65 $86,542 - $161,112	-2,844 Reduced 89.91%	319 $10,000
Q3 2018 Nov 02, 2018	SELL	$46.46 - $68.49 $151,320 - $223,071	-3,257 Reduced 50.73%	3,163 $0
Q2 2018 Jul 24, 2018	BUY	$46.25 - $104.45 $204,147 - $461,042	4,414 Added 220.04%	6,420 $0
Q1 2018 May 03, 2018	SELL	$57.4 - $108.44 $516 - $975	-9 Reduced 0.45%	2,006 $213,000
Q4 2017 Feb 02, 2018	BUY	$23.02 - $60.5 $46,385 - $121,907	2,015	2,015 $121,000

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account